Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications (Q37822462)

23 August 2017

1 reference

title

Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications (English)

1 reference

23 August 2017

1 reference

1 reference

Reem R Al Olaby

1

1 reference

PubMed ID

21171921

23 August 2017

Hassan M E Azzazy

series ordinal

2

1 reference

23 August 2017

1 January 2011

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

23 August 2017

1 reference

23 August 2017

11

1 reference

23 August 2017

1

1 reference

23 August 2017

53-64

1 reference

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

23 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Expert opinion on the treatment of patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Clinical significance of hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Molecular diagnostics of hepatitis C virus infection: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Laboratory Assays for Diagnosis and Management of Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Detection of a healthy carrier of HCV with no evidence of antibodies for over four years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Molecular diagnostic testing for infectious diseases using TMA technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Prognostic significance of hepatitis C virus RNA detection by transcription-mediated amplification with negative polymerase chain reaction during therapy with peginterferon alpha and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Abbott RealTime Hepatitis C Virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV Assays for Prediction of Sustained Virological Response to Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Evaluation of the Abbott Investigational Use Only RealTime Hepatitis C Virus (HCV) Assay and Comparison to the Roche TaqMan HCV Analyte-Specific Reagent Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

TRUGENE sequencing versus INNO-LiPA for sub-genotyping of HCV genotype-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Multiplex Real-Time Reverse Transcription-PCR Assay for Determination of Hepatitis C Virus Genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Rapid Genotyping of Hepatitis C Virus by Primer-Specific Extension Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Hepatitis C virus (HCV) genotyping by annealing reverse transcription-PCR products with genotype-specific capture probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Nanodiagnostics: a new frontier for clinical laboratory medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Nanodiagnostics: application of nanotechnology in molecular diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Nanotechnology in clinical laboratory diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

In vitro diagnostic prospects of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Room-temperature single-nucleotide polymorphism and multiallele DNA detection using fluorescent nanocrystals and microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Gold nanoparticles for molecular diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Gold nanoparticles for the development of clinical diagnosis methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Size- and distance-dependent nanoparticle surface-energy transfer (NSET) method for selective sensing of hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Oligonucleotide-functionalized gold nanoparticles as probes in a dry-reagent strip biosensor for DNA analysis by hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Nucleic acid conjugated nanomaterials for enhanced molecular recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Carbon nanotube transistors for biosensing applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Carbon nanotubes protect DNA strands during cellular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Electrical detection of hepatitis C virus RNA on single wall carbon nanotube-field effect transistors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Screening of serologically negative plasma pools for hepatitis C virus by nucleic acid amplification testing in Croatia, 2001-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

NAT of the United States and Canadian blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Diagnosis of acute hepatitis C: anti-HCV or HCV-RNA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Prolonged PEG-IFN and RBV is effective in patients with HCV genotype 1 and high viral load who achieved virological response later than 24 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

More sensitive hepatitis C virus RNA detection: what for?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Development of an improved genotyping assay for the detection of hepatitis C virus genotypes and subtypes in Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Direct detection of unamplified hepatitis C virus RNA using unmodified gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

Disposable nucleic acid biosensors based on gold nanoparticle probes and lateral flow strip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.101

21 January 2018

Identifiers

DOI

10.1586/ERM.10.101

1 reference

23 August 2017

1 reference

PubMed ID

21171921